A steady stream of structural trial data, approvals, reimbursement decisions, and real-world rollouts arrived in 2025.
Edwards Lifesciences EW announced that the FDA approved its SAPIEN M3 transcatheter mitral valve replacement system, making ...
Background Up to half of patients with infective endocarditis (IE) require cardiac surgery. Although anaemia is common, its precise prevalence, transfusion practices and impact on outcomes in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback